Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy

International Clinical Psychopharmacology

Volumn 16, Issue 6, 2001, Pages 353-355

  Demyttenaere, Koen ^a   Huygens, R ^a   Van Buggenhout, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Tamsulosin; Urinary hesitancy; 1A adrenoceptor antagonist

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; NORADRENALIN UPTAKE INHIBITOR; REBOXETINE; TAMSULOSIN;

ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE INCONTINENCE;

EID: 0034756286     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200111000-00006     Document Type: Article

References (14)

1. Clinical efficacy of reboxetine: A comparative study with desipramine, with methodological considerations
2. The American Urological Association symptom index for benign prostatic hyperplasia
3. Efficacy and tolerabillty of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes
4. Rationale for the development of noradrenaline reuptake inhibitors
5. Alpha-adrenergic blockers for treatment of benign prostatic hyperplasia
6. Alpha-adrenergic blocking drugs in bladder outflow obstruction: What potential has alpha 1 adrenoceptor selectivity?
7. Selective alpha-1 adrenoceptor antagonists in benign prostatic hyperplasia: Rationale and clinical experience
8. Tamsulosin, the first prostate-selective alpha-1A adrenoceptor antagonist. A meta-analysis of two randomised, placebo controlled, multi-centre studies in patients with benign prostatic obstruction
9. Reboxetine versus fluoxetine: An overview of efficacy and tolerability
10. Reboxetine: A double-blind comparison with fluoxetine in major depressive disorder
11. Reboxetine: A review of antidepressant tolerability
12. Tamsulosin: 3-Year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: Analysis of a European, multinational, multicenter, open-label study
13. Doxazosin for reboxetine-induced urinary hesitancy
14. Alpha-1-adrenoceptors in human prostate: Characterisation and binding characteristics of alpha-1-antagonists